{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:34:51Z","timestamp":1791556491332,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.cld.2018.12.009","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T23:49:58Z","timestamp":1550792998000},"page":"279-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Intestinal Failure-Associated Liver Disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Loris","family":"Pironi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Simona","family":"Sasdelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2018.12.009_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.cld.2018.12.009_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clnu.2009.04.001","article-title":"ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients","volume":"28","author":"Staun","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.cld.2018.12.009_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hep.20997","article-title":"Parenteral nutrition-associated liver disease and the role of isolated intestine and intestine\/liver transplantation","volume":"43","author":"Buchman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2018.12.009_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2018.07.006","article-title":"Clinical approach to the management of intestinal failure associated liver disease (IFALD) in adults: a position paper from the home artificial nutrition and chronic intestinal failure special interest group of ESPEN","author":"Lal","year":"2018","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.cld.2018.12.009_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cld.2015.08.009","article-title":"Total parenteral nutrition-induced cholestasis: prevention and management","volume":"20","author":"Beath","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2018.12.009_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MPG.0000000000000586","article-title":"Intestinal failure-associated liver disease: a position paper of the ESPGHAN Working Group of intestinal failure and intestinal transplantation","volume":"60","author":"Lacaille","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cld.2018.12.009_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-132-7-200004040-00003","article-title":"Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure","volume":"132","author":"Cavicchi","year":"2000","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.cld.2018.12.009_bib8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.clnu.2017.04.013","article-title":"Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicentre cross-sectional survey","volume":"37","author":"Pironi","year":"2018","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.cld.2018.12.009_bib9","doi-asserted-by":"crossref","first-page":"1018e22","DOI":"10.1111\/j.1572-0241.1999.01006.x","article-title":"The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating non-alcoholic steatohepatitis from alcoholic liver disease","volume":"94","author":"Sorbi","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2018.12.009_bib10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00125-016-3910-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?","volume":"59","author":"Byrne","year":"2016","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.cld.2018.12.009_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jceh.2016.08.006","article-title":"Histological evaluation of non-alcoholic fatty liver disease and its correlation with different noninvasive scoring systems with special reference to fibrosis: a single center experience","volume":"6","author":"Rath","year":"2016","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2018.12.009_bib12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2018.12.009_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1054\/clnu.2002.0554","article-title":"Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition","volume":"21","author":"Luman","year":"2002","journal-title":"Clin Nutr"},{"key":"10.1016\/j.cld.2018.12.009_bib14","article-title":"Assessment of intestinal failure associated liver disease according to different diagnostic criteria","author":"Sasdelli","year":"2018","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.cld.2018.12.009_bib15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.humpath.2011.07.008","article-title":"Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation","volume":"43","author":"Naini","year":"2012","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.cld.2018.12.009_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-0036-1597771","article-title":"The differentiation of intestinal-failure-associated liver disease from nonalcoholic fatty liver and nonalcoholic steatohepatitis","volume":"37","author":"Buchman","year":"2017","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2018.12.009_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.clnu.2012.05.004","article-title":"Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN","volume":"31","author":"Pironi","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1016\/j.cld.2018.12.009_bib18","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/TP.0b013e31816dd513","article-title":"Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation","volume":"85","author":"Beath","year":"2008","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.cld.2018.12.009_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/0148607114538057","article-title":"Transient elastography (FibroScan) is not correlated with liver fibrosis but with cholestasis in patients with long-term home parenteral nutrition","volume":"39","author":"Van Gossum","year":"2015","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"10.1016\/j.cld.2018.12.009_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/liv.12887","article-title":"Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure","volume":"36","author":"Hukkinen","year":"2016","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.cld.2018.12.009_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/nu9090987","article-title":"Parenteral nutrition-associated liver disease: the role of the gut microbiota","volume":"9","author":"Cahova","year":"2017","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.cld.2018.12.009_bib22","article-title":"Role of the gut\u207bliver axis in driving parenteral nutrition-associated injury","volume":"5","author":"Denton","year":"2018","journal-title":"Children (Basel)"},{"key":"10.1016\/j.cld.2018.12.009_bib23","article-title":"The gut microbiome in patients with intestinal failure: current evidence and implications for clinical practice","author":"Neelis","year":"2018","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.cld.2018.12.009_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ajcn\/51.1.107","article-title":"Comparison of substrate utilization by indirect calorimetry during cyclic and continuous total parenteral nutrition","volume":"51","author":"Just","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cld.2018.12.009_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpedsurg.2008.10.033","article-title":"The association of cyclic nutrition and decreased incidence of cholestatic liver disease in patients with gastroschisis","volume":"44","author":"Jensen","year":"2009","journal-title":"J\u00a0Pediatr Surg"},{"issue":"3","key":"10.1016\/j.cld.2018.12.009_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jpeds.2015.05.048","article-title":"Intestinal microbiota, lipids, and the pathogenesis of intestinal failure-associated liver disease","volume":"167","author":"Lee","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cld.2018.12.009_bib27","article-title":"Intravenous fish oil and pediatric intestinal failure-associated liver disease: changes in plasma phytosterols, cytokines, and bile acids and erythrocyte fatty acids","author":"Calkins","year":"2017","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"6","key":"10.1016\/j.cld.2018.12.009_bib28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1177\/0148607116637855","article-title":"Parenteral plant sterols accumulate in the liver reflecting their increased serum levels and portal inflammation in children with intestinal failure","volume":"41","author":"Hukkinen","year":"2017","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"2","key":"10.1016\/j.cld.2018.12.009_bib29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0016-5085(91)90224-9","article-title":"Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline","volume":"100","author":"Lichtman","year":"1991","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2018.12.009_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0022-4804(85)90049-6","article-title":"A\u00a0possible beneficial effect of metronidazole in reducing TPN-associated liver function derangements","volume":"38","author":"Freund","year":"1985","journal-title":"J\u00a0Surg Res"},{"issue":"25","key":"10.1016\/j.cld.2018.12.009_bib31","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.3748\/wjg.v23.i25.4604","article-title":"Functional lipidomics in patients on home parenteral nutrition: effect of lipid emulsions","volume":"23","author":"Pironi","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2018.12.009_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0884533612439896","article-title":"A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions","volume":"27","author":"Vanek","year":"2012","journal-title":"Nutr Clin Pract"},{"issue":"2","key":"10.1016\/j.cld.2018.12.009_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/gastro\/gov011","article-title":"Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease","volume":"3","author":"Bharadwaj","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"3","key":"10.1016\/j.cld.2018.12.009_bib34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0884533616687500","article-title":"Emerging clinical benefits of new-generation fat emulsions in preterm neonates","volume":"32","author":"Guthrie","year":"2017","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.cld.2018.12.009_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000365608","article-title":"Intravenous lipids in home parenteral nutrition","volume":"112","author":"Pironi","year":"2015","journal-title":"World Rev Nutr Diet"},{"key":"10.1016\/j.cld.2018.12.009_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nut.2018.03.008","article-title":"Intravenous lipid emulsions and liver function in adult chronic intestinal failure patients: results from a randomized clinical trial","volume":"55-56","author":"Klek","year":"2018","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.cld.2018.12.009_bib37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.clnu.2017.07.004","article-title":"Redefining essential fatty acids in the era of novel intravenous lipid emulsions","volume":"37","author":"Anez-Bustillos","year":"2018","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.cld.2018.12.009_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/archsurg.2010.80","article-title":"Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease","volume":"145","author":"de Meijer","year":"2010","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.cld.2018.12.009_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/SLA.0000000000000445","article-title":"The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy","volume":"261","author":"Nandivada","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2018.12.009_bib40","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/j.eclnm.2010.08.003","article-title":"Fish oil-based emulsion for the treatment of parenteral nutrition associated liver disease in an adult patient","volume":"5","author":"Pironi","year":"2010","journal-title":"E\u00a0Spen Eur E J Clin Nutr Metab"},{"issue":"3","key":"10.1016\/j.cld.2018.12.009_bib41","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0148607110382023","article-title":"Omega-3-enriched lipid emulsion for liver salvage in parenteral nutrition-induced cholestasis in the adult patient","volume":"35","author":"Jurewitsch B","year":"2011","journal-title":"J\u00a0Parenter Enteral Nutr"},{"issue":"2","key":"10.1016\/j.cld.2018.12.009_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clnu.2011.10.001","article-title":"Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults","volume":"31","author":"Xu","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1016\/j.cld.2018.12.009_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2018.07.036","article-title":"Intestinal failure in adults: recommendations from the ESPEN expert groups","author":"Pironi","year":"2018","journal-title":"Clin Nutr"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118301132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118301132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:55:48Z","timestamp":1761069348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326118301132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1089326118301132"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2018.12.009","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal Failure-Associated Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2018.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}